Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors

Company Performance - Abbott's stock closed at $118.77, reflecting a -0.15% change from the previous day, underperforming the S&P 500 which gained 0.56% [1] - Over the past month, Abbott's shares increased by 4.92%, while the Medical sector declined by 2.27% and the S&P 500 rose by 3.11% [1] Upcoming Earnings - Abbott is expected to report an EPS of$ 1.34, indicating a 12.61% increase from the same quarter last year, with revenue forecasted at $11.03 billion, up 7.71% year-over-year [2] Full-Year Estimates - The full-year Zacks Consensus Estimates predict earnings of$ 4.67 per share and revenue of $42.01 billion, representing year-over-year growth of +5.18% and +4.73% respectively [3] Analyst Revisions - Recent revisions to analyst forecasts for Abbott are crucial as they reflect near-term business trends, with positive revisions indicating analyst optimism about the company's profitability [3][4] Zacks Rank and Valuation - Abbott currently holds a Zacks Rank of 3 (Hold), with a Forward P/E ratio of 25.47, which is lower than the industry average of 26.43 [5] - The company has a PEG ratio of 2.8, compared to the industry average of 2.37, indicating a higher anticipated earnings growth rate relative to its price [6] Industry Context - The Medical - Products industry, which includes Abbott, has a Zacks Industry Rank of 123, placing it in the top 49% of over 250 industries, suggesting a relatively strong performance [6][7]